Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 275 of 3173 entries
View as:

Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa

Phase: N/A Priority: Normal
NCT ID: NCT01103063 Org: User:
Start: 10/31/10 End: 11/30/13 Due: 11/30/14

Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy

Phase: N/A Priority: Normal
NCT ID: NCT00136968 Org: User:
Start: 04/30/05 End: 05/31/05 Due: 05/31/06

Study Evaluating The Efficacy Of A Novel Ibuprofen Formulation On Fever In Patients With An Uncomplicated Acute Infection

Phase: N/A Priority: Normal
NCT ID: NCT01035346 Org: User:
Start: 01/31/10 End: 05/31/11 Due: 05/31/12

Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00867087 Org: User:
Start: 06/08/09 End: 10/31/12 Due: 10/31/13

A Study to Investigate the Effect of Administration of Ceftazidime-avibactam (CAZ-AVI) and Ceftaroline Fosamil -Avibactam (CXL) on the Intestinal Flora of Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01789528 Org: User:
Start: 08/31/13 End: 03/31/14 Due: 03/31/15

CP-690,550 Thorough QTc Study

Phase: N/A Priority: Normal
NCT ID: NCT01743677 Org: User:
Start: 10/26/07 End: 02/09/08 Due: 02/09/09

US Inhaled Insulin Therapeutic Choice Questionnaire Study

Phase: N/A Priority: Normal
NCT ID: NCT00139763 Org: User:
Start: 07/31/05 End: 03/31/06 Due: 03/31/07

A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)

Phase: N/A Priority: Normal
NCT ID: NCT02187744 Org: User:
Start: 09/23/14 End: 03/09/16 Due: 03/09/17

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years

Phase: N/A Priority: Normal
NCT ID: NCT00761631 Org: User:
Start: 12/31/08 End: 07/31/10 Due: 07/31/11

Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial Formulation

Phase: N/A Priority: Normal
NCT ID: NCT04065633 Org: User:
Start: 07/18/19 End: 12/14/19 Due: 12/14/20

Bioavailability of Bosutinib Administered as Capsule Contents Mixed With Applesauce or Yogurt Relative to Intact Capsules Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT04916769 Org: User:
Start: 08/13/21 End: 01/27/22 Due: 01/27/23

Food Effect Study Of AG-013736 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00918632 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients

Phase: N/A Priority: Normal
NCT ID: NCT03677596 Org: User:
Start: 07/01/19 End: 05/26/23 Due: 05/26/24

Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00782600 Org: User:
Start: 07/31/08 End: 08/31/08 Due: 08/31/09

Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)

Phase: N/A Priority: Normal
NCT ID: NCT04428502 Org: User:
Start: 07/05/20 End: 08/30/20 Due: 08/30/21

Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.

Phase: N/A Priority: Normal
NCT ID: NCT04299048 Org: User:
Start: 11/17/20 End: 03/30/22 Due: 03/30/23

Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain

Phase: N/A Priority: Normal
NCT ID: NCT00415597 Org: User:
Start: 12/31/06 End: 03/31/08 Due: 03/31/09

Drug Interaction Between Ritonavir And Sitaxsentan

Phase: N/A Priority: Normal
NCT ID: NCT01251848 Org: User:
Start: 01/31/11 End: 02/28/11 Due: 02/28/12

A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces

Phase: N/A Priority: Normal
NCT ID: NCT06151418 Org: User:
Start: 11/22/23 End: 04/23/24 Due: 04/23/25

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01889238 Org: User:
Start: 06/12/13 End: 01/10/24 Due: 01/10/25

Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria

Phase: N/A Priority: Normal
NCT ID: NCT03580044 Org: User:
Start: 12/25/20 End: 01/23/23 Due: 01/23/24

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT04507763 Org: User:
Start: 08/01/20 End: 10/01/20 Due: 10/01/21

Study Evaluating the Effects of IMA-638 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00410280 Org: User:
Start: 03/31/07 End: 05/31/08 Due: 05/31/09

Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00355589 Org: User:
Start: 07/31/06 End: 03/31/07 Due: 03/31/08

An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00002089 Org: User:
Start: - End: - Due: -